North America Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Analyte Type, Application, and End User

The independent controls segment by product is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Analyte Type, Application, End-user and Country.” The North America molecular quality controls market is expected to reach US$ 155.61 million by 2028 from US$ 75.79 million in 2021; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028. The report highlights trends prevailing in the North America molecular quality controls market and the factors driving market along with those that act as hindrances.

The North America molecular quality controls market, by product, is segmented into independent controls and instrument specific controls. The independent controls segment held the largest share of the market in 2020 whereas the same is anticipated to register the highest CAGR in the market during the forecast period.

Molecular quality controls are used to detect genetic diseases as these aid in the interpretation of results. Downs Syndrome is a genetic disorder that causes due to abnormal cell division, which results in an extra full or partial copy of chromosome 21. As per the US Centers for Disease Control and Prevention (CDC), every year, around 6,000 newborns in the US suffer from the Down syndrome. As a result, prenatal testing for Down syndrome is increasing in the country. Also, growing awareness of breast cancer increases the adoption of genetic testing for hereditary breast cancer. Further, as per CDC, sickle cell disease (SCD) is a common genetic blood disorder in the US that affects ~70,000 to 100,000 Americans. Thus, the increasing prevalence of such genetic diseases propels the demand for molecular quality controls. Genome sequencing has now become one of the common techniques in clinical practices. The growing implementation of genomic sequencing in healthcare systems is supported by substantial government investments, totaling over US$ 4 billion by at least 14 countries. Such continuous funding by the manufacturers and governments in the field of genomics is supporting the growth of the molecular quality controls market.

The outbreak of the COVID-19 pandemic situation shown some favorable scenario for players operating in the molecular quality controls market. The infection of corona among older people has resulted in severe complications and has accounted for a good number of deaths in the country. But during the pandemic situation, life science companies are engaged in development of novel drugs for the treatment of life threaten diseases. Therefore, molecular quality controls are required in drug design & development as well as COVID-19 diagnosis. In April 2020, Thermo Fisher Scientific launched AcroMetrix Coronavirus 2019 (COVID-19) RNA Control to monitor and validate COVID-19 molecular diagnostic tests. Thus, rising numbers of product launches support the growth of the market and has positive impact on the molecular quality controls market.

Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.

THERMO FISHER SCIENTIFIC INC. BIO-RAD LABORATORIES INC. HOFFMANN-LA ROCHE LTD. Abbott, Quidel Corporation, Qnostics, Maine Molecular Quality Controls Inc. Zeptometrix Corporation, Microbiologics, and Seracare Life Sciences are among the leading companies operating in the North America molecular quality controls market.

The report segments in North America Molecular Quality Controls Market as follows:

By Product

• Independent Controls
• Instrument Specific Controls
• PCR
• DNA Sequencing and NGS

By Analyte Type

• Single Analyte Controls
• Multi Analyte Controls

By Application

• Infectious Diseases
• Oncology
• Genetic Testing
• Other Applications

By End-user

• Clinical Laboratories
• Hospitals
• IVD Manufacturers & Contract Research Organizations
• Academic & Research Institutes
• Other End-users

By Country

• US
• Canada
• Mexico

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America molecular quality controls market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the North America molecular quality controls market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.